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Abstract
Background
In light of the opioid epidemic in the United States, there is growing concern about the use
of opioids in Sweden as it may lead to misuse and overuse and, in turn, severe public health
problems. However, little is known about the distribution of opioid use across different demo-
graphic and socioeconomic dimensions in the Swedish general population. Therefore, we
applied an intersectional Multilevel Analysis of Individual Heterogeneity and Discriminatory
Accuracy (MAIHDA), to obtain an improved mapping of the risk heterogeneity of and socio-
economic inequalities in opioid prescription receipt.
Methods and findings
Using data from 6,846,106 residents in Sweden aged 18 and above, we constructed 72
intersectional strata from combinations of gender, age, income, cohabitation status, and
presence or absence of psychological distress. We modelled the absolute risk (AR) of
opioid prescription receipt in a series of multilevel logistic regression models distinguishing
between additive and interaction effects. By means of the Variance Partitioning Coefficient
(VPC) and the area under the receiver operating characteristic curve (AUC), we quantified
the discriminatory accuracy (DA) of the intersectional strata for discerning those who
received opioid prescriptions from those who did not.
The AR of opioid prescription receipt ranged from 2.77% (95% CI 2.69–2.86) among
low-income men aged 18–34, living alone, without psychological distress, to 28.25% (95%
CI 27.95–28.56) among medium-income women aged 65 and older, living alone, with
psychological distress. In a model that conflated both additive and interaction effects, the
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intersectional strata had a fair DA for discerning opioid users from non-users (VPC = 13.2%,
AUC = 0.68). However, in the model that decomposed total effects into additive and interac-
tion effects, the VPC was very low (0.42%) indicating the existence of small interaction
effects for a number of the intersectional strata.
Conclusions
The intersectional MAIHDA approach aligns with the aims of precision public health, through
improving the evidence base for health policy by increasing understanding of both health
inequalities and individual heterogeneity. This approach is particularly relevant for socioeco-
nomically conditioned outcomes such as opioid prescription receipt. We have identified
intersections of social position within the Swedish population at greater risk for opioid pre-
scription receipt.
Introduction
Opioid prescription in Sweden—Reasons to be aware
Opioid prescription and use are rapidly increasing in high income countries [1]. This phenom-
enon is particularly relevant in the United States, where the existence of an ‘opioid epidemic’ is
considered a major threat to public health [2–6]. In Sweden, such an opioid epidemic has not
yet been identified [7]. Publicly available information [8] indicates that the percentage of peo-
ple receiving opioid dispensation from Swedish pharmacies has slightly decreased from 10.2%
in 2006 to 9.38% in 2015. Men’s values are lower than those of women, during this period, but
present a similar trend. Thus, the proportion of individuals filling a prescription has remained
fairly constant. In any case, the current US opioid epidemic and the evidence indicating risks
of misuse, overdose and mortality due to opioid prescription [2, 3, 5–7, 9, 10] are concerning
facts. These circumstances warrant the investigation of the use of opioids in the Swedish popu-
lation, even in the absence of an overt epidemic in Sweden [7, 11].
Factors associated with opioid use in the population
Recent epidemiological analyses indicate that several demographic and socioeconomic factors
are associated with opioid use. While lower socioeconomic positions (e.g. lower educational
and income levels) appear to correlate with greater risk of opioid prescription receipt [12–15]
and greater risk of opioid-related mortality [10], age and gender seem heterogeneously associ-
ated with opioid misuse and opioid related mortality [3, 7, 16–18].
For example, in the US (2015), while nonmedical use of opioids appears to be most com-
mon among young adults, death due to opioid overdose is most common in adults aged 45–
54, while those aged 55–64 have experienced the greatest increase in overdose mortality in the
past decade [3], and while one study found similar distribution of opioid prescription among
men and women [7], another found higher rates for women [17]. There is further an estab-
lished correlation between weak social support and substance use and misuse [11, 19, 20].
Alongside demographic and socioeconomic factors, psychological distress appears to be
strongly associated with opioid use, dependency and misuse [7, 11, 14, 17].
Knowledge of the demographic and socioeconomic factors that, together with psychological
distress, are associated with opioid use is of major relevance for public health. An improved
mapping of risk in the population will not only allow for effective, targeted strategies to
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promote the safe use of opioids, but also enable identification of societal factors that condition
opioid use over and above individual needs. However, this phenomenon is complex and not
only related to singular demographic or socioeconomic dimensions.
Towards precision public health by Multilevel Analysis of Individual
Heterogeneity and Discriminatory Accuracy (MAIHDA) within an
intersectional framework
Research in (social) epidemiology typically applies demographic and socioeconomic dimen-
sions like gender, ethnicity, income, education and occupation to analyses of disparities in
health. Generally, we observe worse health outcomes among disadvantaged groups, such as
those defined by low income, migrant status, low educational attainment, or unemployment.
However, this conventional epidemiological approach shows some weaknesses.
The conventional approach is based on the study of differences between average risks of
groups defined by demographic, socioeconomic or ethnic categorizations, but without consid-
eration of the discriminatory accuracy (DA) of such categorizations [21]. While differences
between group averages do not account for heterogeneities within or overlaps between groups,
measures of DA inform on the ability of a diagnostic tool, statistical model or risk factor to cor-
rectly discriminate between people with or without the outcome of interest [22]. In the pres-
ence of substantial heterogeneity, DA can be low even if differences in average risk are large.
In such cases, reliance on measures of average risk alone may compromise the effectiveness of
public health interventions and of individual risk assessments. In addition, potentially stigma-
tizing assessments of individuals or groups as high-risk, and targeted intervention aimed
towards such groups, should be avoided if DA is low [21, 23].
Drawing on previous research stressing the relevance of measuring the DA of categoriza-
tions in public health [21, 23–29], we argue that attention to DA aligns with the increasing
emphasis on precision medicine, as well as with a corresponding interest in adopting a preci-
sion public health perspective [30] as a means to provide “precision prevention” through
offering “the right intervention to the right population at the right time” (p 398) [30]. The lat-
ter is furthered through more accurate methods for measuring exposures and vulnerabilities,
including but not limited to biomedical susceptibilities on the individual level [30]. While
precision medicine has been criticized for being overly focused on the individual level, thus
disregarding crucial social determinants of health at the population level [31, 32], this tension
between individual and population perspectives can be addressed by the adoption of a concep-
tual multilevel framework, which integrates individual and population levels of analysis. While
enabling analysis of both between- and within-population heterogeneity, multilevel analysis
does not dislocate these levels from each other, but informs on the share of individual hetero-
geneity that exists at the population level [21, 33].
Multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA),
termed by Merlo [34] and building on previous efforts towards investigating variation between
and within contexts [22, 35, 36], has recently been applied in social epidemiology [37–39]. As
we discuss elsewhere [22, 23, 34], MAIHDA converges with the current movement toward
precision (i.e., individualized, personalized or stratified) medicine, and its efforts toward
understanding individual heterogeneity.
A second weakness of conventional (social) epidemiological approaches to the study of
health disparities, is that these typically investigate singular demographic and socioeconomic
dimensions, like gender, ethnicity, income and education, while failing to account for com-
plexities arising from the intersections of such dimensions. To address this shortcoming, inter-
sectionality theory has increasingly been proposed [40] and used [21, 26, 29, 34, 37, 40–43] as a
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theoretical and methodological framework in social epidemiology. Famously introduced
by the legal scholar Kimberle´ Crenshaw in 1989 [44], intersectionality theory proposes that
societal power structures or axes of differentiation and oppression such as racism and sexism
cannot be fully understood through singular categorical analyses, but must be analyzed as
complex, overlapping, and interacting systems [44].
While previously having been used for investigation of geographical [35, 45] and institu-
tional effects [46, 47] on individual outcomes, MAIDHA has recently incorporated an inter-
sectional approach. Based on studies by Jones et al. [48] and Evans et al. [41, 49] as well as by
our research group [34, 37, 50], intersectional MAIHDA models the individual health outcome
(i.e., opioid prescription receipt in the present case) through a multilevel logistic regression
analysis of individuals (level 1) nested within intersectional strata (level 2). The intersectional
strata consist of a matrix of all possible combinations, or intersections, of the socioeconomic
and demographic variables under study.
An intersectional approach for precision public health
The intersectional MAIHDA provides a number of technical and substantive benefits for the
investigation of socioeconomic disparities in health [34, 38, 39, 48, 49]. Pertinently, the inter-
sectional MAIHDA conceptualizes intersecting dimensions of social position not as essential
characteristics of individuals but as contexts, comparable to neighborhoods and subject to
political and social change [21, 34, 42, 50]. This is done through the modelling of individuals
(level 1, in the multilevel logistic regression analysis) nested within strata consisting of inter-
secting social positions (level 2, in the analysis) [49]. Thus, the noted tendency in quantitative
intersectional study toward assigning causative factors to individuals rather than to structures
or processes is avoided [51]. The risk of “blaming the victim” thereby diminishes, as the inter-
pretational focus on differences between strata is directed toward contextual factors. Further,
in contrast to conventional approaches, MAIDHA does not require the selection of reference
categories (typically male, white, et c.), and thus avoids the associated tendency to reinforce
existing norms of primacy (male, white, et c.) [38] while also enabling the analysis of both mul-
tiply marginalized strata and strata of mixed marginalization and privilege [38].
Benefits of MAIHDA also include improved scalability, through increased capability to
accommodate many intersectional strata, as compared to main effect regression analyses
which require geometrical growth of strata through each individual dimension (e.g., gender,
race/ethnicity or age) that is added to the matrix. MAIDHA offers improved model parsimony,
as intersectional strata are modeled with only one random effects parameter rather than with
separate coefficients for each stratum, and it gives an increased reliability of estimates pertain-
ing to small-size groups, through precision-weighted estimates of risk for each intersectional
stratum, by means of empirical Bayes, posterior, or shrunken predictions [48]. The intersec-
tional MAIHDA also informs on the possible existence of multiple stratum specific interac-
tions of effects in the additive scale. This represents a step forward for interaction analysis, as
the study of interactions in the additive scale has so far been restricted to very few variables at
a time [52]. In addition, the intersectional contingency table or matrix itself, produced by
intersectional MAIHDA, provides a detailed mapping of the distribution of risk, here of opioid
prescription receipt in the population.
Finally, a major reason for using MAIDHA [34] is that the multilevel analysis of variance
considers the total individual variance (i.e., the propensity toward opioid prescription receipt)
as a continuum that can be decomposed at different levels of the analysis, thus enabling the
simultaneous exploration of both between-group and within-group components of individual
heterogeneity. Using MAIHDA, group effects are thereby appraised not only through the
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assessment of differences between strata averages (e.g. relative risk or absolute risk differ-
ences), but also through gauging of the share of the individual heterogeneity (i.e., variance in
the underlying risk of using opioids) that exists at the group level [22, 33–35, 50]. This is the
basis of the concept of intra-class correlation coefficient (ICC) or, in more general terms, of
the variance partition coefficient (VPC), which is a standard measure for the assessment of
clustering or of general contextual effects in multilevel regression models [34–36, 45, 53–55].
The VPC is thereby a measure of DA, as it discerns the accuracy of the categories under study
for classifying individuals with regards to the outcome [21, 23–29, 34, 50]. A corresponding
measure can also be obtained using the area under the ROC curve (AUC) [56]. By thus quanti-
fying the DA of the intersectional strata, intersectional MAIHDA enables avoidance of what
has been referred to as the “tyranny of the averages” in epidemiology [23–25], i.e., the attribu-
tion of the group average risk to all individuals in that group without consideration of the indi-
vidual heterogeneity of outcomes around that average value. In principle, the larger the VPC,
the larger is the share of individual variance attributable to the intersectional strata level. A
high VPC corresponds with an (inter)categorical [57] intersectional approach, which directs
focus toward existing disparities between intersectional strata. Meanwhile, a low VPC relates
to an anti-categorical [57] approach, which questions the validity or usefulness of the social or
intersectional categorizations under study, in relation to the specific outcome at hand [29, 34].
Aims
In the interest of precision public health, and building on the background presented above, we
applied an intersectional MAIHDA to analyze opioid prescription receipt in the total adult
population residing in Sweden during 2010–2011. We combined demographic, socioeconomic
and health characteristics to construct intersectional strata and thereby obtain improved infor-
mation on the distribution and socioeconomic determinants of opioid prescription receipt in
the Swedish population. Thus, we aim to provide an improved basis for decision making in
public health, in line with the aims of precision public health, regarding which population
groups need targeting for prevention of opioid prescription receipt. In doing so, we also seek
to contribute to the use of intersectionality as a useful and relevant analytical framework
within social epidemiology [34].
Population and methods
Database
This study is based on the analysis of data from a large record linkage database constructed
through the merging of several nation-wide registers, via the unique personal identification
number possessed by residents of Sweden. The Swedish Prescribed Drug Register contains
information about every drug dispensation made in Sweden (excluding nursing homes and
hospital wards) by the Anatomical Therapeutic Chemical (ATC) code. The Swedish Patient
Register contains all inpatient and outpatient hospital diagnoses coded according to the 10th
International Classification of Diseases (ICD-10) [58, 59]. The registers mentioned above are
administered by the Swedish National Board of Health and Welfare. Finally, the Longitudinal
Integration Database for Health Insurance and Labor Market Studies, administered by Statis-
tics Sweden, provides demographic and socioeconomic information.
Ethics. The record linkage was performed by the Swedish National Board of Health and
Welfare (Socialstyrelsen) and Statistics Sweden (Statistiska Centralbyrån) after revision by
their data safety committees and approval by the Regional Ethics Review Board in Southern
Sweden (Regionala Etikpro¨vningsna¨mnden i Lund). Personal identifiers were removed before
the database was delivered to the research group.
Intersectional MAIHDA of opioid use in Sweden
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Data accessibility. The original databases used in our study are available from the Swed-
ish National Board of Health and Welfare and Statistics Sweden. In Sweden, register data are
protected by strict rules of confidentiality [60] but can be made available for research after a
special review including approval of the research project by both an Ethics Review Board and
the authorities’ own data safety committees. The Swedish authorities under the Ministry of
Health and Social Affairs do not provide individual level data to researchers abroad. Instead,
they normally advise researchers in other countries to cooperate with Swedish colleagues, to
whom they can provide data according to standard legal provisions and procedures. However,
for the current study, it is technically possible to perform the analysis using a matrix defined
by categories of variables (see the section on intersectional strata). Consequently, the analyses
can be performed using the extended table presented in S1 and S2 Tables. This table is fully
anonymized and contains a considerable number of individuals in each cell. Therefore, to
increase transparency and facilitate the replication of our analysis, we provide the table data as
a Stata dataset (see S1 Data) with an accompanying fully annotated Stata Do-file (see S1 Stata
Do-file).
Study population. The study population consists of all adults (aged 18 and older) residing
in Sweden from January 1st to December 31st, 2010. We excluded a small number of individu-
als with missing sociodemographic data (gender, age, income or civil status) and, similarly to
Shah, Hayes [61], we also excluded individuals with previous overt pain related diagnoses
received at a hospital visit (ICD codes: G43.0-.3, G43.8–43.9, G44.0-G44.4, G44.8, M25.5,
M54.0-M54.9, M79.1, M19.6, N80.0–80.9, R07.0-.4, R10.0-.4, R51.9, R52.0-.2, R52.9), or cancer
diagnoses (ICD codes: C00-D48), or previous substance use disorders (ICD codes: F10-F19).
Our reason for exclusion of individuals with previous pain related diagnoses was our choice to
examine the part of the population whose opioid prescription receipt was not directly medi-
cally warranted. In other words, our study aims focus toward potentially unwarranted use of
opioids in the population, rather than toward treatment of diagnoses for which opioids are
medically indicated.
The final cohort consisted of 6,846,106 adults (Fig 1).
Assessment of variables
The dichotomous outcome variable was opioid prescription receipt (ATC code N02A) between
January 1, 2011 and December 31, 2011 (yes vs. no). This broad operationalization includes
psychiatric conditions that do not directly warrant opioid prescription, but may still motivate
such prescription [62].
Gender was a binary variable (men and women). While this binary categorization may be
problematic, no other gender identification was available in the data.
We divided age into three categories: educational and early working age (18–34 years); later
working age (35–64 years); and retirement age and beyond (65+ years).
As a measure of socioeconomic position [63], we use individualized disposable household
income as provided by Statistics Sweden. To obtain this variable, the total household income
after taxes was divided by the number of individuals in the household, and every individual
received an age-specific weight. We then categorized these income level into tertiles.
We dichotomized cohabitation status as living alone or cohabiting with another adult. Sin-
gle adults living with children were categorized as living alone.
To operationalize psychological distress, we used proxy information on previous dispensa-
tion (from January 1, 2010 to December 31, 2010) of neuroleptics and psychoanaleptics (ATC
codes N05 and N06 respectively), and on the existence of any diagnosis of a mental or behav-
ioral disorder recorded at a hospital (ICD-10 codes F00 to F99). Codes F10 to F19 were not
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included this definition as they were exclusion criteria in the study. We defined psychological
distress as present when such a dispensation or diagnosis code had been recorded.
By including psychological distress in the intersectional strata, we have strayed somewhat
from typical conceptions of intersectionality, as psychological health may not be a social cate-
gory in and of itself. However, there is evidence that stigmatizing conditions such as mental
health disorders have a tangible impact on well-being [64]. Such stigma could have structural
effects similar to those of gender, racialization, or class. In addition, exposure to stressful life
Fig 1. Study population flowchart. We began with all individuals registered in Sweden on December 31, 2011, and
excluded children, those with a cancer diagnosis, a pain diagnosis, or a previous substance use disorder diagnosis
during 2010, as well as a small number of individuals with missing sociodemographic data.
https://doi.org/10.1371/journal.pone.0220322.g001
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events and the ability to insulate oneself from them has been conceptualized as one dimension
of income as a social determinant of health [38]. Further, mental health disorders have been
previously found to be associated with higher rates of opioid use [6, 13, 65–67]. The effects of
mental health, both in terms of stigma and the physical implications of psychological discom-
fort, warrant further investigation in relation to prescription opioid use. This is particularly
relevant as while psychological distress is not an indication for opioid prescription, it is known
that use of opioids is a maladaptive coping strategy among people suffering from such distress
[68].
Intersectional strata. We created 72 intersectional strata consisting of all possible combi-
nations of categories of gender, age, income level, cohabitation status, and psychological dis-
tress, on the basis of available data and known determinants of opioid prescription receipt
(Table 1).
An intersectional MAIHDA
We performed an intersectional MAIHDA [34, 37, 41, 48, 49] with individuals at the first level
and the 72 intersectional strata at the second level. The risk of being dispensed a prescription
of opioids was thus analysed through three successive multilevel logistic regression models.
We estimated the predicted risk and 95% credible interval (CI) associated with each stratum.
Technical details of these models (S1 Statistical Details), as well as the Stata dataset (S1 Data)
and Do-files (S1 Stata Do-file) which can be used to replicate the analyses, are presented in the
supporting information.
Model 1: Simple intersectional model. The first model included only an intercept and a
random effect for the intersectional strata with no covariates. The purpose of this model was
two-fold. First, we performed the simple analysis of components of variance in order to
Table 1. Absolute risk of opioid prescription receipt: Model 1–3.
Gender Age Income Living
alone
Psych.
distress
Observed
opioid use (%)
Model 1 Simple
Intersectional
Model 2b Age
Adjusted
Model 2e
Psych.
Adjusted
Model 3
Interaction
EffectsMale Fem 18–
34
35–
64
65
+
High Med Low No Yes No Yes
7.25 - - - REF
9.95 - - - 1.20(1.14,1.27)
4.38 - REF - REF
8.51 - 2.00(1.42,2.69) - 1.97(1.84,2.11)
14.51 - 2.75(1.98,3.77) - 2.71(2.53,2.89)
7.25 - - - REF
9.38 - - - 1.19(1.11,1.27)
9.47 - - - 1.18(1.10,1.26)
7.95 - - - REF
9.67 - - - 1.09(1.04,1.16)
6.34 - - REF REF
19.81 - - 2.89(2.36,3.52) 2.87(2.71,3.02)
Variance (SD) 0.499(0.087) 0.327(0.057) 0.212(0.037) 0.0138(0.0026)
VPC (%) 13.16 9.04 6.05 0.42
PCV (%) - 34.4 57.5 97.2
Between-intersectional-strata variance, Variance Partition Coefficient (VPC), Proportional Change in Variance (PCV), and absolute risk for opioid use with 95%
credible intervals (CI) for the simple intersectional model 1 (simple components of variance analysis), partially-adjusted model 2 (adjusted for age or for psychological
distress) and intersectional interaction model 3 are here shown. See S1 and S2 Tables and S1 Statistical Details for additional information.
https://doi.org/10.1371/journal.pone.0220322.t001
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calculate the VPC, which indicates the share of the total individual variance in the propensity
for opioid prescription receipt that is accounted for at the intersectional strata level. To calcu-
late the VPC, we used the most popular version derived from the latent response formulation
of the model [69, 70], computing it as:
VPC ¼
s2u
s2u þ 3:29
ð1Þ
Here, s2u denotes the between-stratum variance in the propensity for opioid prescription
receipt while 3.29 indicates the within-stratum between-individual variance constrained equal
to the variance of the standard logistic distribution. We multiplied the VPC by 100 and inter-
preted it as the percentage share of the individual variance which lies between strata.
For additional information, complementary to the VPC, we also calculated the area under
the receiver operating characteristic curve (AUC) using the predicted probabilities obtained
from each model. The AUC measures the ability of the model to classify individuals with or
without the outcome (e.g., presence or absence of opioid prescription receipt) as a function
of individuals’ predicted probabilities, thus also measuring DA [56, 71, 72]. The AUC takes a
value between 1 and 0.5, where 1 represents perfect discrimination and 0.5 indicates that the
covariates have no predictive power [73] (see S1 Statistical Details).
The second purpose of model 1 was to use the shrunken predicted stratum random effects
to calculate stratum-specific risks of opioid prescription receipt and, thereby, to obtain an
improved mapping of the disparities in opioid prescription receipt. For this purpose, we calcu-
lated the risk of opioid prescription receipt and its 95% CI for every intersectional stratum. To
do so, and in order to use an additive scale, we transformed the predicted logit (log-odds) of
using opioids in in stratum j into the predicted probability of opioid use in stratum j (see S1
Statistical Details). As the predicted probability in our study represents the absolute risk (AR)
of an opioid dispensation, we use the term “risk” rather than predicted probability.
Model 2: Partially-adjusted intersectional model. The purpose of the partially adjusted
model was to quantify the degree to which the different dimensions used to construct the
intersectional strata contributed to the between-stratum variance observed in the previous
model. In different versions of model 2, we expanded model 1 by adjusting for one covariate at
a time (i.e., a different model for each dimension). Thereafter, we calculated the Proportional
Change in the between-stratum Variance (PCV):
PCV ¼
s2uð1Þ   s
2
uð2Þ
s2uð1Þ
ð2Þ
where s2uð1Þ and s
2
uð2Þ denote the between stratum variance obtained from models 1 and 2
respectively. PCVs are typically multiplied by 100 and reported as percentages.
Model 3: Intersectional interaction model. Model 3 expands on model 1 by simulta-
neously including all of the variables used to construct the intersectional strata as covariates
with fixed effect regression coefficients. In this way, model 3 disentangles the main (additive)
effects from the interaction effects. In the absence of stratum specific interactions, the main
effects of the variables used to construct the intersectional strata (i.e., gender, age, income
level, cohabitation status, and psychological distress) would completely explain the between
stratum variance and all 72 stratum random effects would equal zero. If this is not the case,
and assuming no relevant variables were omitted, the stratum random effects represent the
existence of interaction effects between the variables. Therefore, in model 3 the stratum vari-
ance and the corresponding VPC inform on the existence of intersectional multiplicative inter-
action effects, at least in relation to the set of variables included.
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We also used model 3 to calculate the total risk of opioid prescription receipt (based on
main and interaction effects) and the risk of opioid prescription receipt based on the main
effects only. By subtracting the risk attributable to main effects only from the total risk, we iso-
lated the absolute risk due to interaction (ARI) in the additive scale for each intersectional stra-
tum. A positive ARI means that individuals in that intersectional stratum have a higher risk
than expected based on the simple addition of the risks conveyed by the variables that define
the intersectional stratum, while a negative ARI means a lower risk than expected. We also cal-
culated 95% CIs for all ARs as well as ARIs.
Software. We ran the models using MLwiN 3.00 [74, 75] by calling it from within Stata
14.1 using the runmlwin command [76]. The estimations were performed using Markov chain
Monte Carlo (MCMC) methods [77].
Results
Fig 2 maps the simple intersectional model (model 1) strata-specific ARs for opioid prescrip-
tion receipt. The numerical values are available in S1 and S2 Tables. We found the lowest
AR for opioid prescription receipt among low income men, aged 18–34, living alone, without
psychological distress (AR = 2.77%, 95% CI 2.69–2.86). We observed the highest AR for pre-
scription of opioids in the stratum consisting of medium income women, aged 65-years or
Fig 2. Absolute risk of opioid prescription receipt for intersectional strata. Absolute risk of opioid prescription receipt and 95% Credible Intervals
(CI) by intersectional strata for individuals aged 18 years or more residing in Sweden from January 1, 2010 to December 31, 2011. Exact numerical
values for each stratum are presented in S1 and S2 Tables.
https://doi.org/10.1371/journal.pone.0220322.g002
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older, living alone, with psychological distress (AR = 28.25%, 95% CI 27.95–28.56). That is, the
highest AR was 10 times higher than in the group with the lowest AR.
Overall, model 1 (Table 1) shows that the AR for opioid prescription receipt tended to be
higher in strata with psychological distress, and lower in strata including younger age.
The VPC from this simple intersectional model further indicates that as much as 13.2% of
the total variance among individuals was located at the intersectional strata level (Table 1). The
AUC for model 1 was 0.68 (Fig 3), suggesting a moderate DA.
Fig 3. Discriminatory accuracy of intersectional strata. ROC curve analysis obtained in the simple intersectional model 1, quantifying the
discriminatory accuracy of the intersectional strata for classifying individuals according to opioid prescription receipt.
https://doi.org/10.1371/journal.pone.0220322.g003
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We can ascertain how much of the between stratum variance that is explained by the com-
ponents of the intersectional strata by comparing the VPC and PCV values. In model 2 we
adjusted for each of the intersectional component variables separately. Age was found to
explain 34.4% of the between stratum variance, leading the VPC to drop to 9.04%. Psychologi-
cal distress explains 57.5% of the between stratum variance, leading the VPC to drop to 6.05%.
The intersectional interaction model (model 3) reduced the between-strata variance consid-
erably (PCV = 97.2%) indicating that the differences between strata were mainly due to the
additive, rather than the interaction, effects of the variables used for their definition. However,
we could still observe conclusive ARIs for certain strata (Fig 4).
Table 2 shows the five most positive and the five most negative ARIs observed in model 3
(see S2 Table for ARI values and 95% CIs for all strata). The largest positive (i.e. hazardous)
ARIs were found among the strata comprising men and women with low income and psycho-
logical distress, aged 35–64 and cohabiting, and among low income women living alone, aged
35–64 years, with psychological distress.
The largest negative (i.e. protective) ARIs occurred among women aged 65 and older,
cohabiting, with high or medium income and with psychological distress, as well as among
high income women living alone, aged 35–64, with psychological distress.
Fig 4. Absolute risk due to interaction. Absolute risk due to interaction (ARI) obtained in the intersectional interaction model 3 in relation to opioid
prescription receipt during 2011 for adults residing in Sweden on December 31, 2010, by intersectional strata. Point estimates are ARIs and 95%
Credible Intervals (CI). Exact numerical values for each stratum are presented in S1 and S2 Tables.
https://doi.org/10.1371/journal.pone.0220322.g004
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We present the differences between ARs due to total stratum specific effects and ARs due to
only main effects of the variables that define the intersectional strata in Fig 5.
Discussion and conclusions
More precise information on socioeconomic disparities and heterogeneity
of risk
Our intersectional MAIHDA study detected socioeconomic disparities in the absolute risk of
opioid prescription receipt and, thereby, confirms findings from previous studies both within
Sweden [12] and from the United States [13, 14]. However, our findings reveal that these dis-
parities are not unidimensional, but rather intersectional and complex. The stratification of
the population in accordance with an intersectional perspective that considers gender, age,
income, cohabitation status and, in particular, psychological distress, provides more precise
information for identifying candidate population groups for targeted interventions, to pro-
mote evidence-based opioid use and to prevent the potential misuse of opioids. By providing
measures of DA, we avoid the risk of “tyranny of the averages” and of inaccurate identification
of risk groups [23]. The DA of the intersectional stratification used was moderate (as indicated
by the VPC and AUC). Therefore, public health policies should not only focus on the intersec-
tional strata with a high absolute risk of opioid prescription receipt, but also on the population
as a whole.
In correspondence with other recent studies [41, 42, 49], our analysis applies an innovative
method for investigation of socioeconomic disparities in health outcomes in general, and in
the use of prescription opioids in particular. As compared to more conventional studies, our
intersectional matrix provides a more nuanced understanding of the complex associations
between opioid use, psychological distress and relevant socioeconomic factors such as age,
Table 2. Absolute risk due to interaction (ARI), model 3.
Stratum # Gender Age Income Living
alone
Psych.
distr.
Model 3
Total Predicted
Percentage (95%
Credible Interval)
Model 3
Main Effects only
Predicted Percentage
(95% Credible
Interval)
Model 3
Interaction
Effects = Total—
Main Effects (95%
Credible Interval)
Male Fem 18–34 35–64 65+ High Med Low No Yes No Yes
Five Intersectional Strata with the most negative (protective) Interaction Effects
62 19.27 (18.81, 19.74) 22.18 (20.82, 23.56) -2.91 (-4.38, -1.50)
66 22.59 (22.22, 23.01) 25.24 (23.82, 26.71) -2.65 (-4.17, -1.23)
52 16.49 (7.87, 8.70) 18.50 (17.43, 19.74) -2.02 (-3.33, -0.90)
12 8.28 (16.14, 16.83) 10.22 (9.50, 10.96) -1.94 (-2.76, -1.15)
64 22.33 (6.41, 6.59) 23.75 (22.4, 25.24) -1.42 (-2.98, 0.01)
Five Intersectional Strata with the most positive (hazardous) Interaction Effects
20 20.10 (19.66, 20.61) 18.35 (17.19, 19.55) 1.75 (0.49, 3.00)
71 13.29 (13.09, 13.49) 11.38 (10.63, 12.18) 1.90 (1.06, 2.67)
56 24.17 (23.76, 24.59) 21.19 (19.95, 22.47) 2.98 (1.59, 4.25)
58 22.80 (22.45, 23.16) 19.72 (18.51, 20.92) 3.07 (1.88, 4.28)
22 21.78 (21.32, 22.24) 17.03 (15.87, 18.12) 4.75 (3.63, 5.98)
The table shows the intersectional strata with the five most positive and the five most negative absolute risk due to interaction (ARI) observed in the intersectional
interaction model 3. The ARI is calculated by subtracting the absolute risk due to the main effects of the variables that define the intersectional strata from the total
stratum specific absolute risk.
https://doi.org/10.1371/journal.pone.0220322.t002
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gender, and income [1, 3]. The stratum-specific interaction effects we calculated allow us to
explore the unique ways in which the intersections influence the risk of opioid prescription
receipt. In this way, intersectional MAIHDA contributes toward precision public health aim-
ing to improve targeted prevention strategies based on representative population data [30].
Simple categorizations are misleading, as is evidenced by the strata with hazardous and protec-
tive interaction effects. In particular, the strata comprised by cohabiting low income men and
women with psychological distress had a greater risk of opioid prescription receipt than would
be predicted by the covariate main effects alone. Particular attention should therefore be paid
to these population groups when prescribing opioids.
Limitations
Despite the benefits of applying MAIHDA within an intersectional framework, some limita-
tions should be noted.
First, while MAIHDA is an appropriate method for analyzing strata with low numbers of
individuals, because it provides precision weighted estimates [48], as with any other form of
analysis the accuracy with which we can estimate the stratum specific absolute risks will
increase with sample size. In other words, in spite of the inherent advantage of the shrinkage
Fig 5. Absolute risk due to interaction: Total and main effects. Presentation of the absolute risk due to interaction (ARI) calculated by subtracting the
absolute risk due to the main effects of the variables that define the intersectional strata from the total stratum specific absolute risk. Exact numerical
values for each stratum are presented in S2 Table.
https://doi.org/10.1371/journal.pone.0220322.g005
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factor to prevent erratic estimations for small strata, larger samples of individuals are always
preferred to ensure the most reliable estimates for all strata. In our study of nearly 7 million
individuals, we did not face this particular challenge.
As our intersectional matrix was composed by a limited number of variables, we cannot
exclude the possibility that the observed ARIs are not true interactions but are rather due to
the main effect of some omitted variable. However, it is possible that omitted variables are
mediators of the socioeconomic variables defining the strata, rather than common causes (i.e.,
confounders) of being located in a specific intersectional stratum and using opioids. In any
case, the VPC of 0.4% in the interaction analysis represents the upper bound of the possible
interactions.
Although the sociodemographic categories selected to construct the intersectional strata
were based on a priori assumptions from previous studies, we were limited by the available
data (for example, binary gender categories) and we did not have access to prescription data
of individuals residing in nursing homes or in-hospital care data. Also, in the Swedish classi-
fication of family units, unmarried adults without children are categorized as living alone
even if they share a home, and this categorization may thus be overestimated [78]. Further-
more, previous findings in Sweden indicate that low education is associated with increased
risk of opioid use [12]. Income and education are both proxies for socioeconomic position
and when deciding to include a dimension of socioeconomic position in the definition of
the strata we selected income. Even if the multilevel analysis accounts for the reliability of the
strata information (i.e., through shrunken residuals), preventing under/overestimation of
the strata averages, it does not increase reliability itself. Incorporating more dimensions in
the strata would allow for a better understanding of potential intersectional heterogeneity,
but decrease the reliability in some strata. Nevertheless, we believe our strata definition pro-
vides an improved picture of opioid use across demographic and socioeconomic dimensions
in Sweden.
Third, most intersectional MAIHDA studies have an explorative approach. In conventional
studies, the theory and a priori hypotheses justifying the investigation of the association
between simple measures of socioeconomic position (e.g., education, income and occupation)
and health-related outcomes are well established [79]. Therefore, most conventional studies of
health inequalities are deductive even if the hypotheses are not always explicitly stated. How-
ever, in the analysis of an intersectional matrix we do not necessarily have an established
hypothesis for each of the intersectional strata. Even so, this approach provides worthy induc-
tive information on socioeconomic differences in health. The new methodology increases our
understanding of the dynamics of privilege and disadvantage that drive the production of
health disparities, which is not only interesting from an epidemiological point of view, but also
from a socioeconomic one.
Further, and as discussed elsewhere [34], the reader should be aware that there are funda-
mental differences between qualitative analysis within social sciences and quantitative epide-
miology when it comes to the application of intersectional frameworks. From a normative
perspective, intersectional social categorizations or identities cannot be decomposed and are
not easily captured in statistical models [80, 81]. Nevertheless, from the perspective of social
epidemiology, the quantitative analysis and decomposition of intersectional strata, as well as
the analysis and validation of categorical and anti-categorical approaches to intersectionality,
seem feasible [34]. We believe that tensions between approaches can be negotiated, for pur-
poses of joining forces to denounce unjust health disparities.
Finally, our study population excluded individuals with previous pain-related diagnoses,
due to our interest in investigating opioid prescription receipt that was not directly medically
warranted, and our outcome variable was quite broad as it included any opioid prescription
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related to a range of psychiatric conditions. It is possible that the results would be different,
should the study have been operationalized differently.
In conclusion
Opioid use is a complex topic, encompassing growing concerns about increasing misuse and
mortality, economic and social costs, and efficacy for pain management [2, 11]. This study is,
to our knowledge, the first to implement an intersectional MAIHDA approach regarding opi-
oid prescription receipt in Sweden, and we have found meaningful patterns of opioid prescrip-
tion receipt across social strata. We have pointed to social strata with higher absolute risk for
opioid prescription receipt, and by decomposing the model into additive effects and interac-
tion effects, we have identified which strata had greater risk than anticipated for opioid pre-
scription receipt. Recent public health data in Sweden indicate that prescription of oxycodone
in particular has been increasing [7]. In the case of the USA, oxycodone (OxyContin) was
largely responsible for the sharp increase in opioid prescriptions during the 1990s [3], and
we therefore propose that a future intersectional MAIHDA study should assess oxycodone
in particular. Intersectional MAIHDA has the potential to be an important methodological
resource for precision public health. From this perspective, intersectional MAIHDA provides
an improved mapping of socioeconomic disparities of health outcomes, and a stronger eviden-
tiary foundation for prevention strategies. Concerning opioid prescription receipt in Sweden,
our findings suggest the need for public health policy that targets the groups with the highest
risk, but simultaneously employs population-level strategies to promote adequate opioid use in
the general population.
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